A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
DSpace Repositorium (Manakin basiert)
- Publikationsdienste
- →
- Universitätsbibliographie
- →
- 4 Medizinische Fakultät
- →
- Dokumentanzeige « zurück
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Stenzl, Arnulf | |
| dc.date.accessioned | 2017-07-13T07:11:47Z | |
| dc.date.available | 2017-07-13T07:11:47Z | |
| dc.date.issued | 2016 | |
| dc.identifier.issn | 1423-0399 | |
| dc.identifier.uri | http://hdl.handle.net/10900/76945 | |
| dc.language.iso | en | en |
| dc.publisher | Karger | de_DE |
| dc.relation.uri | http://dx.doi.org/10.1159/000381589 | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject.ddc | 610 | de_DE |
| dc.title | A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | de_DE |
| dc.type | Article | de_DE |
| utue.quellen.id | 20160915142648_02310 | |
| utue.publikation.seiten | 5-13 | de_DE |
| utue.personen.roh | Miller, Kurt | |
| utue.personen.roh | Morant, Rudolf | |
| utue.personen.roh | Stenzl, Arnulf | |
| utue.personen.roh | Zuna, Ivan | |
| utue.personen.roh | Wirth, Manfred | |
| dcterms.isPartOf.ZSTitelID | Urologia Internationalis | de_DE |
| dcterms.isPartOf.ZS-Issue | 1 | de_DE |
| dcterms.isPartOf.ZS-Volume | 96 | de_DE |
| utue.fakultaet | 04 Medizinische Fakultät |
Dateien zu dieser Ressource
| Dateien | Größe | Format | Anzeige |
|---|---|---|---|
|
Zu diesem Dokument gibt es keine Dateien. |
|||
Das Dokument erscheint in:
-
4 Medizinische Fakultät [31081]